EGFR and head and neck squamous cell carcinoma: Preclinical research in wild‐type EGFR HNSCC cell lines already demonstrated that cotreatment with afatinib enhances the therapeutic effect of platinum‐based chemotherapy such as cisplatin (Brands et al., 2016).